Unraveling Lennox-Gastaut Syndrome: Molecular Pathogenesis and Therapeutic Strategies
Lennox-Gastaut syndrome treatment challenges arise from its complex network dysfunction and drug-resistant seizures. Precision medicine approaches targeting molecular pathways offer new hope. CBD has shown efficacy as adjunctive therapy for this severe…
Cannabidiol for Lennox-Gastaut: Cannabinoid Clinical Trials
Clinically meaningful reduction in drop seizures has been observed in Lennox-Gastaut syndrome patients treated with cannabidiol. Clinical trials show that even reductions below 50% can improve patient quality of life. Caregiver-reported outcomes align…
Cannabidiol for Lennox-Gastaut: Clinical Trial Evidence and Insights
Clinically meaningful cannabidiol reduction offers new hope for Lennox-Gastaut syndrome patients by improving drop seizure outcomes. Recent clinical trials demonstrate that even reductions below 50% can be impactful. Caregiver reports support…